China Universal Asset Management Company’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $67.6K | Buy |
|
|||||
|
2024
Q3 | $105K | Buy |
|
|||||
|
2024
Q2 | $31.5K | Sell |
|
|||||
|
2024
Q1 | $83.5K | Buy |
|
|||||
|
2023
Q4 | $89.3K | Buy |
|
|||||
|
2023
Q3 | $25.8K | Buy |
|
|||||
|
2023
Q2 | $27.9K | Sell |
|
|||||
|
2023
Q1 | $36.1K | Buy |
|
|||||
|
2022
Q4 | $15.4K | Buy |
|
|||||
|
2022
Q3 | $18K | Buy |
|